Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 17:07, 24 September 2020
   
Page name:

22 September 2020

 m   22:19  Paclitaxel (Taxol)‎ (diff | hist) . . (+114)‎ . . Jwarner (talk | contribs) (→‎History of changes in FDA indication)
 m   22:00  Interferon alfa-2b (Intron-A)‎ (diff | hist) . . (+80)‎ . . Jwarner (talk | contribs) (→‎History of changes in FDA indication)
 m   21:58  Interferon alfa-2a (Roferon-A)‎ (diff | hist) . . (+80)‎ . . Jwarner (talk | contribs) (→‎History of changes in FDA indication)
 m   20:54  Carboplatin (Paraplatin)‎ (diff | hist) . . (+178)‎ . . Jwarner (talk | contribs) (→‎History of changes in FDA indication)
 m   14:21  Aldesleukin (Proleukin)‎ (diff | hist) . . (+77)‎ . . Jwarner (talk | contribs) (→‎History of changes in FDA indication)
Retrieved from "https://hemonc.org/wiki/Special:RecentChangesLinked/Category:Melanoma_medications"